You were stable on one GLP-1, and a letter says your plan now covers a different one. This is a business decision between your plan and the manufacturers — not a judgment about your treatment — and you have more options than the letter suggests.
Verified Aug 11, 2026Quick answer: you can switch to the preferred drug (with your prescriber setting the new starting dose), or file a formulary exception if there's a documented reason the preferred drug won't work for you. Both paths are routine and published.
Every example below is a real formulary action with an official notice or published appeal decision behind it.
The largest pharmacy benefit manager in the country removed Zepbound from its major commercial formularies mid-year, steering members to Wegovy instead. Members didn't do anything wrong — the PBM negotiated a different deal. (Caremark has since announced Zepbound returns as a preferred option in late 2026; these lists genuinely move both ways.)
The opposite direction: Massachusetts Medicaid made Zepbound its preferred weight-loss GLP-1 and denies Wegovy prior authorizations on that basis. Published appeal decisions show members being switched — and show that exceptions get granted when there's a documented medical reason the preferred drug won't work.
California's Medicaid program removed Wegovy, Zepbound, and Saxenda from weight-loss coverage entirely on a date certain. A formulary switch can be a removal, not a swap — which changes your options from "switch drugs" to "appeal, or find another payment path."
Most people resolve this at step 2 or 3.
Plans must notify you of formulary changes that affect you. Find the notice (mail or member portal) — it names the preferred alternative and the effective date, which sets your timeline.
If the preferred drug is medically reasonable for you, switching is usually faster than appealing — but the medications aren't interchangeable pens. Your prescriber sets the starting dose on the new drug; it's often not the milligram number you were on.
A documented medical reason — you already failed the preferred drug, or it's contraindicated — is exactly what exception processes exist for. Your prescriber submits it with clinical notes.
The standard machinery applies: internal appeal (generally within 180 days), then independent external review that the plan is bound by. The published MassHealth decisions above are people doing precisely this.
When a drug is removed without a covered alternative you can use, compare manufacturer self-pay programs and savings cards before assuming treatment ends.
This page explains publicly available insurance processes and cites published formulary actions. It is not medical, legal, or insurance advice — switching medications is a clinical decision made with your prescriber.